Access
To read this story in full you will need to login or make a payment (see right).
News
Nature Medicine 9, 9 (2003)
doi:10.1038/nm0103-9a
Microarray to be used as routine clinical screen
Charlotte M. Schubert1
- New York
The Netherlands Cancer Institute in Amsterdam is to become the first institution in the world to use microarray techniques for the routine prognostic screening of cancer patients. Aiming for a June 2003 start date, the center will use a panoply of 70 genes to assess the tumor profile of breast cancer patients and to determine which women will receive adjuvant treatment after surgery.
To read this story in full you will need to login or make a payment (see right).
